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Background: Epidemiological studies have revealed that intrauterine growth retardation (IUGR) or low birth weight
is linked to the later development of asthma. Epigenetic regulatory mechanisms play an important role in the fetal
origins of adult disease. However, little is known regarding the correlation between epigenetic regulation and the
development of asthma following IUGR.
Methods: An IUGR and ovalbumin (OVA)-sensitization/challenge rat model was used to study whether epigenetic
mechanisms play a role in the development of asthma following IUGR.
Results: Maternal nutrient restriction increased histone acetylation levels of the endothelin-1 (ET-1) gene promoter
in lung tissue of offspring, but did not cause significant alterations of DNA methylation. The effect was maintained
until 10 weeks after birth. Furthermore, these epigenetic changes may have induced IUGR individuals to be highly
sensitive to OVA challenge later in life, resulting in more significant changes related to asthma.
Conclusions: These findings suggest that epigenetic mechanisms might be closely associated with the
development of asthma following IUGR, providing further insight for improved prevention of asthma induced by
environmental factors.
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An adverse intrauterine environment, such as that result-
ing from maternal malnutrition, may impact the develop-
ment of the fetus resulting in fetal growth restriction or
intrauterine growth retardation (IUGR) [1,2]. There is a
wealth of epidemiological evidence to show that IUGR or
lower birth weight is strongly correlated with an increased
risk of adult diseases, such as type 2 diabetes mellitus,
hypertension, and cardiovascular disease. This is called the
“developmental origins of adult disease” theory or the
“Barker” hypothesis [2]. Advances in perinatal or neonatal
medicine have improved the survival of infants with* Correspondence: dulizhong@zju.edu.cn
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unless otherwise stated.IUGR, leading to an increase in the prevalence of adult
diseases.
Studies have showed that IUGR or low birth weight
was associated with medium and small airway obstruc-
tion, and altered lung function, including decreased
forced expiratory volume in 1 s (FEV1), FEV1/forced
vital capacity and forced mid-expiratory flow rate [3-5].
A number of studies have found a relationship between
lower birth weight and asthma in children [6-8]. Fur-
thermore, low birth weight predisposes an individual to
develop asthma, and those who later become overweight
adolescents have reduced lung function and the highest
prevalence of asthma [9]. All respiratory function vari-
ables measured were significantly decreased in extremely
low birth weight children compared with normal birth
weight controls [10]. A recent meta-analysis showed that
preterm birth and higher weight gain in infancy were
closely associated with childhood asthma [11]. A studyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Sampling age of different experimental group rats.
Upward arrows represent sampling times, solid triangles represent
the times of interventions, d1 represents 1 day after birth.
OVA = ovalbumin; IP = intraperitoneal injections.
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associated with a significantly greater risk of asthma in-
dependent of gestational age, sex, year of birth, or
maternal age, parity, or socioeconomic status; among
monozygotic twins, birth weight less than 2500 g was
related to increased risks of asthma [12]. These investiga-
tions further revealed that, in addition to shared environ-
mental or genetic factors, other regulatory mechanism
such as DNA methylation or histone modifications might
be involved in the development of asthma following either
IUGR or low birth weight.
An increasing number of studies have showed that epi-
genetics plays an important role in the fetal origin of
adult disease [13]. Epigenetics refers to all heritable
changes in phenotype or gene expression states that are
not involved in the DNA sequence itself. To date, epi-
genetic mechanisms in adult-onset diseases following
IUGR, including type 2 diabetes mellitus, hypertension,
and pulmonary arterial hypertension, have been exten-
sively investigated [14-18]. However, whether epigenetics
is involved in the pathogenesis of asthma following
IUGR or low birth weight is not clear.
There is evidence that intrauterine nutrient (calorie)
restriction may cause changes not only in placental DNA
methylation [19], but may also affect epigenetic mecha-
nisms in organs of the offspring. Our previous studies
found that maternal nutrient restriction increased histone
acetylation and hypoxia inducible factor-1α binding levels
of the endothelin-1 (ET-1) gene promoter in pulmonary
vascular endothelial cells from IUGR newborn rats, which
continued up to 6 weeks after birth. These epigenetic
changes resulted in an IUGR rat being highly sensitive to
hypoxia later in life, causing more significant pulmonary
arterial hypertension or pulmonary vascular remodeling
[18,20]. A large number of studies have confirmed that
asthma is an inflammatory airway disease characterized by
bronchoconstriction and hyperreactivity with influx of in-
flammatory cells, mucus production, edema, and airway
remodeling, while ET-1 has an important role in each of
these processes [21,22]. Increased expression of ET-1 was
strongly associated with the development of asthma
[23-26]. Based on this evidence, we hypothesized that
intrauterine nutrient restriction may not only cause epi-
genetic changes of the ET-1 gene at the endothelial cellu-
lar level, but cause epigenetic alterations of the ET-1 gene
at a lung tissue level and persist into later life. Further-
more, we hypothesized that these epigenetic changes of
lung tissue would induce an individual to be highly sensi-
tive to allergens or other stimuli, resulting in more signifi-
cant airway inflammation or asthma presentation.
In the present study, an IUGR rat model induced by
maternal nutrient restriction was used to investigate the
level of histone acetylation and DNA methylation of ET-1
gene promoter region in lung tissues from 1-day-old and10-week-old IUGR rats, and the reactivity of IUGR rats to
ovalbumin (OVA) allergen challenge was assessed.Methods
Intrauterine growth retardation (IUGR) rat model
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Committee on the
Ethics of Animal Experiments of Zhejiang University.
All surgery was performed under sodium pentobarbital
anesthesia, and all efforts were made to minimize suffer-
ing. The IUGR rat model was established based on our
previous study [18]. Virgin female Sprague–Dawley rats
weighing 250-300 g obtained from Zhejiang University
Laboratory Animal Center were mated overnight. The
pregnant rats were randomly divided into two nutri-
tional groups: a control group, and an under-nutrition
group. Pregnant rats in the control group were fed a
standard commercial rat diet, while pregnant rats in the
under-nutrition group were fed the same diet at 50% of
the free intake throughout gestation until birth. Both
groups of rats were kept in the same room and had free
access to water. Those pups whose birth weight was
below the 10th percentile of normal birth weight were
defined as IUGR. The litter size was culled to five pups
per litter to assure adequate nutrition until weaning.
The newborn pups from the control group were consid-
ered as a normal birth weight group, referred to as
“Control d1”, and those newborn pups from the under-
nutrition group were referred to as “IUGR d1”. Newborn
IUGR rats continued to be reared by diet-restricted
mothers that received normal food intake through lacta-
tion, while the control pups were reared by control
mothers. Both groups of rats were raised until 10 weeks
of age. The sampling ages of the different experimental
group rats are presented in Figure 1.
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Six-week-old IUGR and control rats were respectively
sensitized by an intraperitoneal injection of 100 mg of
ovalbumin (OVA, Sigma, USA) together with 100 mg
Al(OH)3 in 1 ml 0.9% NaCl on the 1st day of the 7th
and 8th weeks. After this 2-week sensitization, different
groups of rats (each group containing 8–10 animals) were
exposed to aerosolized OVA for 2 weeks. The aerosol was
generated with an ultrasonic nebulizer (PARI, Germany)
and was introduced into an exposure chamber. The me-
dian aerosol particle size was 3.9 μm according to the
manufacturer’s specifications. The concentration of OVA
in the nebulizer was 10% (wt/vol), and the duration of ex-
posure was 30 min. The control and IUGR rats with OVA
exposure were referred to as “Control OVA” and “IUGR
OVA”, respectively. Lung tissues of different age groups
were obtained, frozen in liquid nitrogen and stored at −80°C
for further study.
The serum IgE level and hematoxylin and eosin (H&E)-
stained lung tissue were used to evaluate rat asthma
model. Serum was obtained by lethal cardiac puncture in
anesthetized rats and stored at −80°C for measurement of
IgE by ELISA. In H&E-stained lung sections, the number
of eosinophils per square millimeter in the peribronchial
and perivascular tissue was assessed using Image Pro Plus
software (Media Cybernetics). More than eight bronchi-
oles and pulmonary arteriole in a minimum of 10 high-
power fields per lung tissue were randomly examined in a
blinded fashion [27].
Western blot detection for endothelin-1 protein
Total protein extracts were prepared and protein con-
centrations measured according to our previous studies
[28,29]. Total protein extracts were prepared from lung
tissues in a RIPA lysis buffer (50 mM Tris, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) contain-
ing protease inhibitors. Protein concentrations were mea-
sured using a BCA assay method. Thirty microgram
protein extracts were resolved on 8-10% SDS polyacryl-
amide gels for ET-1 (21 kDa) proteins. Proteins were trans-
ferred onto a polyvinylidene fluoride membrane using a
BioRad gel blotting apparatus. Membranes were incubated
with a primary antibody against ET-1 (ab2786, abcam,
1:300 in antibody diluent) overnight at 4°C and with a
peroxidase-conjugated secondary antibody for 60 min. To
confirm equivalent sample loading, β-actin was used as an
internal control. The bands of Western blots were quanti-
tated by densitometry and normalized to β-actin using
Image Pro Plus software (Media Cybernetics).
Lung tissue histological and immunohistochemistry
assessment
Lung tissue was fixed in formaldehyde solution and em-
bedded in paraffin. The tissue was sectioned at a thicknessof 4–5 μm, and stained with H&E solution for analyzing
the difference between eosinophils [29]. For immunohisto-
chemistry, the paraffin sections were rehydrated and
transferred to 100% methanol with 3% hydrogen peroxide
to eliminate endogenous peroxidase activity. Sections were
then rinsed with PBS, and blocked with blocking serum
before incubation with a primary antibody against ET-1
(ab2786, abcam, 1:250 in antibody diluent) overnight.
Control sections were incubated with PBS instead of the
primary antibody. A systematic sampling method was
used to evaluate random, non-overlapping calibrated fields
for each variable, and the terminal bronchioles were used
as the independent landmark for selecting a small pul-
monary arteriole [29,30]. We used Image Pro Plus soft-
ware (Media Cybernetics) to make the measurements.
Tissue sections were analyzed by one without knowledge
of the group from which the tissue was taken. At least
eight slides from each lung were taken and analyzed.
Quantitative real-time PCR for ET-1
Total RNA was isolated from lung tissues according to the
RNeasy protocol (Axygen). RNA was reverse-transcribed
to cDNA using a reverse transcriptase kit (Takara) accord-
ing to manufacturer’s protocols. Reverse-transcribed PCR
analysis was performed using 37°C for 15 min, followed by
85°C for 5 s. Real-time quantitative PCR was performed
using the ABI Prism 7500 Instrument following the Takara
protocol. PCR was carried out in triplicate from each frac-
tion using 94°C for 3 min, followed by 40 cycles of 94°C
for 15 s and 60°C for 1 min. β-Actin was used as an in-
ternal control. Primer sequences for ET-1 (NCBI Refer-
ence Sequence: NM_012548.2) and β-actin are as follows:
forward: 5’-aagcagacaaagaactccgag-3’, reverse: 5’-cgctttcaac
tttgcaactcg-3’; forward: 5’-gccaaccgtgaaaagatg-3’, reverse:
5’-tgccagtggtacgaccag-3’, respectively.
Bisulfite genomic DNA sequencing
Bisulfite genomic DNA sequencing was performed as
described in our previous study [28]. Genomic DNA was
extracted from lung tissue and treated with 3 M sodium
bisulfite as described previously. Briefly, DNA was dena-
tured with 2 M NaOH and then treated with 10 mM
hydroquinone and 3 M sodium bisulfite. After purifica-
tion using the Wizard SV Plus kit column, the DNA was
treated with 3 M NaOH and precipitated with 3 volumes
of 100% ethanol, one-third volume of 10 M NH4OAc,
and 2 μL of glycogen. The chemically modified DNA
was then subjected to PCR. PCR was amplified using an
ET-1 promoter-specific bisulfate primer (5’-agatttttaaaag
ttagaggygattaga-3’, and 5’-tctaatcrcctctaacttttaaaaatct-3’).
Reactions were performed in a 25-μL volume containing
0.2 μM dNTPs, 10 mM Tris–HCl, 50 mM KCl, 2 mM
MgCl2, 0.2 μM primer and 0.75 units of AmpliTaq Gold.
PCR products were purified and cloned. The cloned
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M forward primer and a PRISM AmpliTaq DNA Poly-
merase FS Ready Reaction Dye Terminater Sequencing
kit. Re-amplified DNA fragments were purified with
Centri-Sep Columns and sequenced with an ABI PRISM
310 Genetic Analyzer.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was per-
formed as described in a previous study [28]. A 100 mg
sample of lung tissue was ground in liquid nitrogen, and
fixed with formaldehyde. The cell pellets were sus-
pended in lysis buffer and centrifuged, and the superna-
tants were discarded. The pellets were resuspended in
SDS lysis buffer, sonicated, centrifuged and aliquots of
soluble chromatin were collected. Aliquots of the super-
natants were retained for representing the input chro-
matin. Aliquots were incubated overnight at 4°C with
one of the following antibodies: 5 μL anti-acetylaled
Histone H3 (06–599, Millipore), 5 μL anti-acetylated
Histone H3 (Lys9) (H3K9, 07–352, Millipore), or 5 μL
anti-acetylaled Histone H4 (06–866, Millipore). The im-
mune complexes were precipitated with Protein A beads
and then eluted. The input, unbound and bound frac-
tions were incubated with 5 M NaCl to reverse crosslink.
The DNA fragments were purified using the Qiaquick
PCR Purification kit (Qiagen). The DNA fragments con-
taining ET-1 site-specific sequences were quantified using
real-time PCR. Relative quantification of PCR products
were based on value differences between the bound and
input using the △△Ct method. The PCR primers for the
ET-1 gene promoter were as follows: ET-1 promoter A1,
F5’-ttgcctgtgggtgactaatc-3’, R5’-ccttcaccggagcgaaag-3’ (−197
to +25); ET-1 promoter A2, F5’-cctcttgattcttgaactctggg-3’,
R5’-attagtcacccacaggcaac-3’ (−397 to −179).
Statistic analysis
Values are expressed as mean ± SEM (standard error of
mean). The continuous variables in the different groups
were compared by one-way analysis of variance. Multiple
comparisons were performed using the Student–Newman–
Keuls test. A difference of P <0.05 was considered to be
statistically significant.
Results
Establishment of rat IUGR OVA-exposed model
Our previous study showed that the 10th percentile for
normal newborn rat birth weight was 5.87 g. Newborn
rats weighing less than 5.80 g were considered to be
IUGR [18]. The offspring rats from pregnant rats fol-
lowed by diet restriction were in accordance with IUGR
criteria. The average weight of 10-week IUGR rats was
significantly lower than that of 10-week control rats
(367.5 ± 5.4 g vs 389.3 ± 7.0 g, P = 0.027). The averageweight of 14-week IUGR and Control rats were 479 ±
8.4 g and 457 ± 9.1 g, respectively; there was no statis-
tical difference between them (P = 0.1). The IgE levels
from Control and IUGR 10-week rats were 13.73 ± 1.07
and 14.95 ± 0.48 ng/mL respectively, and there was no
statistical difference between them (P = 0.51). After OVA-
sensitizing/challenging, the serum IgE levels were sig-
nificantly increased compared with non-OVA-exposed
rats (P <0.05). Furthermore, the serum IgE level in rats
from the IUGR OVA group was higher than that in rats
from the Control OVA group (26.20 ± 1.84 ng/mL and
22.09 ± 1.20 ng/mL respectively, P = 0.048).
A marked infiltration of inflammatory cells into peri-
bronchiolar and perivascular lesions in the lung tissue
sections from the OVA-exposed rats was observed com-
pared with the non-OVA-exposed groups. Most of the
infiltrating inflammatory cells were eosinophils. Tissue
sections from the OVA-exposed IUGR rats exhibited
more prominent eosinophil infiltration compared with
the OVA-exposed Control rats. This phenomenon was
observed mainly in the perivascular regions of the lung
(Figure 2G, H).
Lung tissue endothelin-1 (ET-1) levels and pathological
changes
The ET-1 protein level of the IUGR d1 group was simi-
lar to that of the Control d1 group (P = 0.524). However,
the ET-1 expression levels increased with age (Figure 3).
Although the ET-1 protein level of the IUGR 10 wk
group appeared to be higher than the age-matched con-
trol group, there was no statistically significant differ-
ence between them (P = 0.147). Lung tissue ET-1 protein
expression levels in IUGR OVA and Control OVA-
exposed groups were significantly higher than other
non-OVA-exposed groups (P <0.05). Furthermore, the
ET-1 level of the IUGR OVA group was significantly
higher than that of the Control OVA group (P <0.01).
Similar to protein expression patterns, the ET-1 mRNA
levels increased with age (Figure 4). Lung tissue ET-1
mRNA levels in IUGR and Control OVA-exposed groups
were significantly higher than in non-OVA-exposed
groups (P <0.05). Moreover, the ET-1 mRNA level of the
IUGR OVA group was significantly higher than that of
Control OVA group (P = 0.017). These results indicate
that the sensitivity to OVA in IUGR rats was significantly
higher than in the normal control group.
Significant histological changes consistent with asthma
were observed in lung tissues of the OVA-challenged rat
models. These included increased ET-1 expression in the
airway, and infiltration of inflammatory cells (Figure 2).
ET-1 protein was mainly expressed in vascular endothe-
lial cells and airway epithelial cells. In comparison with
the age-matched control and IUGR rat groups, the
number of airway epithelial cells expressing ET-1 was
Figure 2 Representative immunohistochemical staining for ET-1 (brown) and H&E staining in lung tissues from control 10 weeks (A, E),
IUGR 10 weeks (B, F), Control OVA (C, G), and IUGR OVA (D, H) groups (×200). The relative immunostaining densities for ET-1 from
OVA-challenged groups were significantly higher than those from non-OVA-exposed groups, especially from IUGR OVA group. There were
relatively few eosinophils infiltrations in the Control (E) and IUGR (F) rats. Tissue sections from the OVA-exposed IUGR (H) rats exhibited more
predominant eosinophils infiltration compared with the OVA-exposed control rats (G) (×200). The histogram (I) showed the number of infiltrated
eosinophil cells in peribronchiolar and perivascular lesions. **P <0.01 as compared with Control 10 weeks and IUGR 10 weeks groups, respectively;
##P = 0.001 as compared with Control OVA group. PA = pulmonary artery; AW = airway (n = 8).
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cially those in the IUGR OVA group (Figure 2D). More-
over, there was significant inflammatory cell infiltration
in the lung tissue from IUGR OVA group (Figure 2H).
Methylation status of CpGs in the ET-1 core promoter of
lung tissue
Nineteen CpG sites within the proximal promoter of the
rat ET-1 gene were analyzed for methylation status. Rep-
resentative results of bisulfate genomic DNA sequencing
analysis are shown in Figure 5. Generally, 19 CpG dou-
blets of the proximal promoter were lightly methylated
in lung tissue. Only the +70 site was hypermethylated,
whereas sites +45, +43, +17, +6, +1, −19, −33, and −96
were hypomethylated, and sites +12, +3, −9, −23, −59,
−73, −75, −99, and −144 were unmethylated. At the +70
site, methylation rates were 80% and 90% in IUGR and
Control d1 groups, 80% and 90% in the IUGR and Con-
trol 10-week groups, and 70% and 60% in the IUGR and
Control OVA-exposed groups respectively, there were
no statistically significant differences for any of thesecomparisons (P = 0.50). In other CpG sites, no signifi-
cant differences were observed. These results show that
intrauterine malnutrition was not sufficient to cause a
significant change in DNA methylation of the ET-1 gene.
The ET-1 gene promoter histone code in lung tissue
Two sites in the ET-1 gene promoter were analyzed for
acetylated histone H3, H3K9, and H4. Acetylation levels
of each site in the IUGR groups were quantified by
ChIP/real-time PCR and are expressed as a fold-change
relative to the same site in the age-matched Control
groups. The levels of acetylated histone H3 in the ET-1
promoter A1 region of lung tissue from IUGR d1, IUGR
10wks, and IUGR OVA groups were significantly higher
than those from the age-matched Control groups (P =
0.039, 0.025, and 0.008, respectively). In the ET-1 pro-
moter A2 region, there was no statistically significant
difference between IUGR and Control groups (P >0.05,
Figure 6A). A trend of acetylated H3K9 levels in the ET-1
promoter in lung tissue was similar to the observed
change in acetylated histone H3 (Figure 6B).
Figure 3 Expression of lung tissue ET-1 proteins was measured
using Western blot analysis. The bar graph represents the relative
ET-1 levels (percent of Control d1 ± SEM). #P <0.05 as compared with
Control d1, IUGR d1, Control 10 weeks, and IUGR 10 weeks groups,
respectively; **P <0.05 as compared with Control d1, IUGR d1,
Control 10 weeks, IUGR 10 weeks, and Control OVA groups,
respectively; note increased ET-1 expression in the IUGR OVA group.
β-actin protein expression served as an internal control and was
used to normalize the protein band intensity (n = 4).
Figure 4 Relative ET-1 mRNA levels were examined by
quantitative real-time PCR. Note that the ET-1 mRNA levels
increased with age. *P <0.05 as compared with control d1, and IUGR
d1, respectively; #P <0.05 as compared with control d1, IUGR d1,
Control 10 weeks, and IUGR 10 weeks, respectively; **P <0.05 as
compared with control d1, IUGR d1, Control 10 weeks, IUGR
10 weeks, and Control OVA group, respectively (n = 4).
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promoter A1 region from IUGR d1 and 10-week groups
were higher than those of the age-matched Control
groups (Figure 6C), there was no statistical significance
between them (P = 0.135, and 0.39, respectively). However,
the level of acetylated histone H4 in the ET-1 promoter
A1 region of the IUGR OVA group was significantly (P =
0.02) higher than that of the Control OVA group. Similar
to the changes of acetylated H3 and H3K9, there was no
statistically significant difference in the changes of acety-
lated H4 in the ET-1 promoter A2 region between IUGR
and Control groups.
The ChIP experiments revealed that histone acetylation
of the ET-1 gene promoter might induce the higher sensi-
tivity of IUGR rats to OVA, leading to the ET-1 protein
expression and airway hyper-responsiveness.
Discussion
The main finding of this study is that maternal nutrient
restriction increased the histone acetylation levels in the
ET-1 gene promoter of lung tissue from IUGR newborn
rats, but was insufficient to cause significant DNA meth-
ylation alterations. The effect could also be observed10 weeks after birth. Furthermore, these epigenetic
changes induced IUGR individuals to be highly sensitive
to OVA challenge later in life, resulting in more significant
changes related to asthma.
Epigenetics is the study of mitotically heritable changes
in phenotype that occur without direct alterations of the
DNA sequence itself. These epigenetic changes include
DNA methylation, histone modification, and aberrant ex-
pression of microRNAs [31]. Generally, DNA methylation
of a gene promoter region can directly repress transcrip-
tion. Increased levels of histone acetylation are associated
with increased transcriptional activity, whereas decreased
levels of acetylation are closely correlated with suppressed
gene expression [1]. Multiple epigenetic mechanisms are
involved in regulation of asthma-related genes known to
initiate and maintain the asthma phenotype and its symp-
toms [31]. There is evidence that exposure to adverse en-
vironmental factors during prenatal or postnatal life
triggers the early airway to undergo a different course of
development, resulting in a phenotype of increased sensi-
tivity to allergens or irritants, hyperresponsiveness, and a
skewed TH2 response. Exposure of pregnant mice to a
diet rich in methyl donors increased the risk of allergic air-
way disease in the offspring through inducing methylation
changes of asthma-related genes [32]. Maternal polycyclic
aromatic hydrocarbons (PAH) exposure induced promoter
methylation of an asthma related gene, IFN-γ, in cord
white blood cells from children in a study cohort [33].
These findings demonstrate that dietary factors can alter
asthma risk through epigenetic mechanisms during a
susceptible period of developmental reprogramming. Our
Figure 5 Methylation profiles of the ET-1 core promoter in lung tissue from IUGR and control rats are shown. The proximal promoter
sequence of ET-1 (−149 to +80) is shown. Methylated CpG sites are indicated by solid black circles and unmethylated CpGs are depicted by grey
circles. Arrows represent transcription start sites. Each line of circles represents independent PCR clones (n = 10). The bar graph represents CpG
methylation percentage at each site, there was no significant difference between the Control and IUGR animals. Only the +70 site was
hypermethylated, whereas sites +45, +43, +17, +6, +1, −19, −33, and −96 were hypomethylated, and the sites +12, +3, −9, −23, −59, −73, −75,
−99, and −144 were unmethylated. There were no significantly statistical differences between Control and IUGR rats (P >0.05) at any of CpG sites.
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crease histone acetylation levels of the ET-1 gene pro-
moter in rat lung tissue. Increased histone acetylation at
the ET-1 gene promoter in IUGR rats is essential for tran-
scription. Upregulated ET-1 protein expression in lung tis-
sue from the IUGR asthma group rats is closely associated
with the presence of increased acetylated histones. Reduc-
tion of these markers in Control asthma rats results in de-
creased ET-1 protein expression.
The lung has the highest levels of ET-1 secreted by
endothelium, smooth muscle, and airway epithelium. In
the airway, ET-1 is primarily localized to the bronchial
smooth muscle with low expression in the epithelium
[22]. ET-1 is a potent bronchoconstrictor, being approxi-
mately 100 times more potent than methacholine in
asthma [21]. In a murine asthma model, ET-1 was
shown to direct airway remodeling and hyper-reactivity
[34]. The release of ET-1 from bronchial epithelium may
play an important role in the increase of airway inflam-
mation which was observed after postexercise broncho-
constriction in asthmatic patients [35]. These findings
indicate that ET-1 is an important mediator in the devel-
opment of asthma. Consistent with the regulation of the
expression of many genes, ET-1 expression is also regu-
lated by epigenetic mechanisms, and some transcription
factor binding sites are present in the ET-1 proximalpromoter region [36-38]. In the present study, IUGR rats
with OVA exposure showed significantly increased ET-1
mRNA and protein levels in lung tissue. Furthermore,
the immunohistochemical localization indicated that the
number of airway epithelial cells expressing ET-1 signifi-
cantly increased in OVA-exposed rats, especially those
in the IUGR OVA group. These results further demon-
strated that the increased ET-1 levels (including protein
and mRNA levels) in lung tissues from OVA-exposed
rats might be induced mainly by airway epithelial cells.
The high ET-1 expression from IUGR OVA-exposed rats
could be closely associated with increased histone acetyl-
ation within the ET-1 gene promoter.
In our study, ChIP was performed to analyze the levels
of histone acetylation in the ET-1 gene promoter. The
rat ET-1 promoter contains consensus sequences that
are required for transcription factor binding. Our results
indicate that acetylation levels of histone H3 and histone
H4 significantly increased in lung tissue from IUGR
newborn rats compared with Controls. In the two ET-1
promoter regions that we investigated, acetylation levels
of histones within the proximal promoter region were
higher in histone H3 or H4, although there was no sig-
nificantly statistical difference in histone H4. In contrast,
histone acetylation levels in the promoter region furthest
from the transcription start site in IUGR rats were not
Figure 6 Comparison of histone H3 (A), H3K9 (B), and H4 (C) acetylation levels at the ET-1 promoter between IUGR and control rats
using ChIP and relative quantitative real-time PCR. A1 and A2 represent two areas of the ET-1 gene promoter (−197 to +25, and −397 to −179,
respectively). Data are expressed as IUGR percent of the Control ± SEM. *P <0.05 as compared with Control groups. Note that the levels of
acetylated histone H3 and H3K9 in the ET-1 promoter A1 region of lung tissue from IUGR groups were significantly higher than those from the
age-matched Control groups; while in the ET-1 promoter A2 region there was no significant statistical difference between IUGR and Control
groups. The level of acetylated histone H4 in the ET-1 promoter A1 region of the IUGR OVA group was significantly higher than that of the
Control OVA group (n = 4).
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trols. These findings indicate that nutrient restriction in
uterine may not only cause epigenetic alteration of the
ET-1 gene in pulmonary vascular endothelial cells, but
may induce epigenetic alteration of the ET-1 gene
throughout the whole lung, probably including endothe-
lial cells, airway epithelial cells, and smooth muscle cells.
Furthermore, these epigenetic markers may persist until
10 weeks after birth, and induce an IUGR individual to
be highly sensitive to allergen challenge later in life,
resulting in more significant changes associated with
asthma. In our previous study, persistent pulmonary
hypertension of the newborn induced by short-term
hypoxia and indomethacin treatments in uterine were
not sufficient to cause significant CpG methylation in
the endothelial nitric oxide synthase promoter. In the
present study, maternal nutrient restriction was insuffi-
cient to induce significant methylation changes in the
ET-1 promoter. Whether the methylation status of CpG
islands of other genes associated with asthma is involved
in the underlying mechanism requires further research.
Epigenetic modifications of the ET-1gene in part ex-
plain the phenomenon of significant asthma-linked
changes in IUGR OVA-exposed rats. This also further
confirms the fetal origins of adult disease hypothesis and
provides a potential mechanism of fetal programming.Because of the potential reversibility of epigenetic mech-
anisms, some appropriate interventions during the early
stage of life may be likely to reduce the risk of adult dis-
ease through preventing or reversing the epigenetic
modifications of the correlated genes. In addition to ET-1,
there might be other factors involved in the development
of asthma following IUGR. This would be worthy of fur-
ther investigation. Nevertheless, caution is necessary when
attempting to apply information from a rat model to hu-
man pathophysiology. Given the non-specificity of some
interventions that influence epigenetic mechanisms, we
did not analyze histone acetylation levels of the ET-1 gene
in lung tissue after such an intervention in the present
study, and have not yet investigated the corresponding
epigenetic changes in the next generation. Possible strat-
egies for an early intervention and the potential identifica-
tion of epigenetic biomarkers require further study.
Conclusions
We found that maternal nutrient restriction increased
histone acetylation levels of the ET-1 gene promoter in
lung tissue, but was insufficient to cause significant
DNA methylation alterations. The effect persisted until
10 weeks after birth. These epigenetic changes may in-
duce an IUGR individual to be highly sensitive to OVA
(allergen) challenge later in life, resulting in more
Xu et al. Respiratory Research 2014, 15:137 Page 9 of 10
http://respiratory-research.com/content/15/1/137significant changes related to asthma. These findings
suggest that epigenetics might be closely associated with
the development of asthma following IUGR, providing
further insight for improved prevention of asthma in-
duced by environmental factors.
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